Serum Institute of India

News

FDA Allows Use of Recombinant BCG Through Expanded Access Program

Recombinant BCG Offers Fresh Promise in Bladder Cancer Care The U.S. Food and Drug Administration (FDA) has approved a new…

Read More »
Back to top button